1996
DOI: 10.1021/jm9509410
|View full text |Cite
|
Sign up to set email alerts
|

De Novo Antimicrobial Peptides with Low Mammalian Cell Toxicity

Abstract: De novo antimicrobial peptides with the sequences: (KLAKKLA)n, (KLAKLAK)n (where n = 1,2,3), (KALKALK)3, (KLGKKLG)n, and (KAAKKAA)n (where n = 2,3), were prepared as the C-terminus amides. These peptides were designed to be perfectly amphipathic in helical conformations. Peptide antibacterial activity was tested against Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus. Peptide cytotoxicity was tested against human erythrocytes and 3T3 mouse fibroblasts. The 3T3 cell testing was a much more s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
339
0
12

Year Published

2000
2000
2022
2022

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 490 publications
(366 citation statements)
references
References 34 publications
4
339
0
12
Order By: Relevance
“…What makes AMPs attractive therapeutics is their selective activity against prokaryotes. Earlier studies established that the peptide (KLAKLAK) 2 is a highly effective antibacterial agent with low toxicity (3). Particularly promising is the D (KLAKLAK) 2 (all-D-enantiomer peptidomimetic synthetic version of the designed L-or mixed D/L-peptide), the focus of McGrath et al's article in PNAS (4).…”
Section: From Natural To Synthetic Antibacterial Peptidesmentioning
confidence: 99%
“…What makes AMPs attractive therapeutics is their selective activity against prokaryotes. Earlier studies established that the peptide (KLAKLAK) 2 is a highly effective antibacterial agent with low toxicity (3). Particularly promising is the D (KLAKLAK) 2 (all-D-enantiomer peptidomimetic synthetic version of the designed L-or mixed D/L-peptide), the focus of McGrath et al's article in PNAS (4).…”
Section: From Natural To Synthetic Antibacterial Peptidesmentioning
confidence: 99%
“…The data of antibacterial activity were used only when the growth inhibition zone had a diameter ≥10 mm. MICs were determined by microdilution method by adding 100 µL of each strain suspended in Brain Heart Infusion Broth (final concentration 10 5 cfu/mL) to a 96 well micro titer plate with wells containing 100 µL of two fold serial dilutions of extracts (5). The final concentrations of extract were 512 to 8 µg/mL.…”
Section: Methodsmentioning
confidence: 99%
“…Each inoculum (100 mL) was distributed in each well of a microtiter 96 wells plate and then submitted to a twofold serial dilution using 100 mL of the ethanol extract, with concentrations ranging between 8 and 1024 mg mL -1 . The plates were incubated for 24 hours at 35°C (JAVADPOUR et al 1996). Bacterial MIC was determined using resazurin, with blue changing to red indicating bacterial growth.…”
Section: Minimum Inhibitory Concentrationmentioning
confidence: 99%